Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.
Preliminary research suggests that NG101, a drug from Neurogastrx, may lower the risk of nausea and vomiting in people taking ...
Do the blood thinners have anything to do with the low platelet count? The cardiologist recently reduced the Xarelto dosage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback